TheraRadar
← Back
Data updated: Mar 29, 2026

PTS CONSULTING

Pharmaceuticals
Generics

PTS CONSULTING is a generic drug manufacturer with 2 FDA-approved products.

2020
Since
2
Drugs
-
Trials
9
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

TOLTERODINE TARTRATE 2025-08-21
Labeling
DOXEPIN HYDROCHLORIDE 2025-08-06
TOLTERODINE TARTRATE 2025-06-17
Labeling
DOXEPIN HYDROCHLORIDE 2024-08-27
Labeling
DOXEPIN HYDROCHLORIDE 2024-08-27
Labeling
TOLTERODINE TARTRATE 2024-08-27
DOXEPIN HYDROCHLORIDE 2024-07-25
DOXEPIN HYDROCHLORIDE 2024-07-23
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...